J.-Z. Yuan, B.-Q. Fu, M.-W. Ding, G.-F. Yang
91%). M.p.: 252–253 °C. 1H NMR (CDCl3, 400 MHz): δ = 1.50 (s, (89), 217 (67), 183 (88), 77 (100). C14H16N4OS (288.4): calcd. C
FULL PAPER
6 H, 2 CH3), 6.19 (s, 1 H, N–H), 7.27–7.68 (m, 9 H, Ar–H) ppm.
13C NMR (CDCl3, 100 MHz): δ = 24.6 (2 C), 75.6, 120.0 (2 C),
126.6 (2 C), 129.0, 129.3 (2 C), 130.0, 130.2, 131.1 (2 C), 135.3,
151.5, 154.1, 174.7 (C=O) ppm. MS: m/z (%) = 353 (8) [M]+, 325
(85), 283 (100), 234 (48), 76 (61). C18H16ClN5O (353.8): calcd. C
61.11, H 4.56, N 19.79; found C 61.18, H 4.47, N 19.71.
58.31, H 5.59, N 19.43; found C 58.15, H 5.45, N 19.47.
3,5-Dihydro-5,5-dimethyl-3-phenyl-2-propylthio-6H-imidazo[1,2-b]-
1,2,4-triazol-6-one (16b): White solid (yield 0.27 g, 88 %). M.p.:
1
111–112 °C. H NMR (CDCl3, 400 MHz): δ = 1.04 (t, J = 7.2 Hz,
3 H, CH3), 1.50 (s, 6 H, 2 CH3), 1.78–1.84 (m, 2 H, CH2), 3.20 (t,
J = 7.2 Hz, 2 H, SCH2), 7.46–7.54 (m, 5 H, Ar–H) ppm. 13C NMR
(CDCl3, 100 MHz): δ = 13.2, 22.1, 24.6 (2 C), 33.5, 76.4, 125.7 (2
C), 129.3, 130.1 (2 C), 130.4, 156.0, 159.4, 174.4 (C=O) ppm. MS:
2-(2-Chlorophenylamino)-3,5-dihydro-5,5-dimethyl-3-phenyl-6H-
imidazo[1,2-b]-1,2,4-triazol-6-one (13c): White solid (yield 0.29 g,
83%). M.p.: 253–254 °C. 1H NMR (CDCl3, 400 MHz): δ = 1.51 (s, m/z (%) = 302 (17) [M]+, 273 (53), 231 (100), 189 (31), 76 (61).
6 H, 2 CH3), 7.00–7.69 (m, 9 H, Ar–H), 8.41 (s, 1 H, N–H) ppm.
13C NMR (CDCl3, 100 MHz): δ = 24.6 (2 C), 75.7, 119.7, 121.6,
124.0, 126.2 (2 C), 128.3, 128.9, 129.9, 130.2, 131.0 (2 C), 133.4,
151.1, 153.9, 174.8 (C=O) ppm. MS: m/z (%) = 353 (23) [M]+, 325
(100), 284 (67), 76 (21). C18H16ClN5O (353.8): calcd. C 61.11, H
4.56, N 19.79; found C 61.25, H 4.74, N 19.95.
C15H18N4OS (302.4): calcd. C 59.58, H 6.00, N 18.53; found C
59.64, H 5.86, N 18.44.
2-Butylthio-3,5-dihydro-5,5-dimethyl-3-phenyl-2-butylthio-6H-imid-
azo[1,2-b]-1,2,4-triazol-6-one (16c): White solid (yield 0.26 g, 82%).
M.p.: 114–116 °C. 1H NMR (CDCl3, 400 MHz): δ = 0.92 (t, J =
7.6 Hz, 3 H, CH3), 1.51 (s, 6 H, 2 CH3), 1.40–1.79 (m, 4 H,
CH2CH2), 3.23 (t, J = 7.2 Hz, 2 H, SCH2), 7.44–7.56 (m, 5 H, Ar–
H) ppm. 13C NMR (CDCl3, 100 MHz): δ = 13.5, 21.8, 24.6 (2 C),
3,5-Dihydro-5,5-dimethyl-2-(3-methylphenylamino)-3-phenyl-6H-
imidazo[1,2-b]-1,2,4-triazol-6-one (13d): White solid (yield 0.29 g,
87%). M.p.: 250–251 °C. 1H NMR (CDCl3, 400 MHz): δ = 1.48 (s, 31.2, 32.3, 76.3, 125.7 (2 C), 129.4, 130.1 (2 C), 130.3, 156.0, 159.5,
6 H, 2 CH3), 2.34 (s, 3 H, CH3), 6.08 (s, 1 H, N–H), 6.91–7.65 (m,
174.3 (C=O) ppm. MS: m/z (%) = 316 (10) [M]+, 292 (31), 230
9 H, Ar–H) ppm. 13C NMR (CDCl3, 100 MHz): δ = 21.5, 24.7 (2 (100), 182 (57), 76 (34). C16H20N4OS (316.4): calcd. C 60.73, H
C), 75.5, 115.9, 119.2, 124.8, 126.6 (2 C), 129.2, 130.2 (2 C), 131.1
(2 C), 136.5, 139.4, 151.1, 153.9, 174.8 (C=O) ppm. MS: m/z (%) =
333 (9) [M]+, 305 (100), 264 (78), 214 (21). C19H19N5O (333.4):
calcd. C 68.45, H 5.74, N 21.01; found C 68.53, H 5.57, N 21.25.
6.37, N 17.71; found C 60.62, H 6.34, N 17.76.
3,5-Dihydro-5,5-dimethyl-2-ethoxycarbonylmethylthio-3-phenyl-6H-
imidazo[1,2-b]-1,2,4-triazol-6-one (16d): White solid (yield 0.29 g,
85%). M.p.: 109–110 °C. 1H NMR (CDCl3, 400 MHz): δ = 1.32 (t,
J = 7.2 Hz, 3 H, CH3), 1.48 (s, 6 H, 2CH3), 4.04 (s, 2 H, SCH2),
4.26 (q, J = 7.2 Hz, 2 H, OCH2), 7.46–7.54 (m, 5 H, Ar-H) ppm.
2-(n-Butylamino)-3,5-dihydro-5,5-dimethyl-3-phenyl-6H-imidazo-
[1,2-b]-1,2,4-triazol-6-one (13e): White solid (yield 0.24 g, 81%).
M.p.: 217–218 °C. 1H NMR (CDCl3, 400 MHz): δ = 0.93 (t, J = 13C NMR (CDCl3, 100 MHz): δ = 14.0, 24.9 (2), 34.6, 61.9, 76.4,
7.2 Hz, 3 H, CH3), 1.28–1.64 (m, 4 H, CH2CH2), 1.45 (s, 6 H, 2 125.5 (2), 129.5, 130.1 (2), 130.4, 158.6, 159.4, 174.4 (C=O) ppm.
CH3), 3.33–3.38 (m, 2 H, NCH2), 4.13 (s, 1 H, N–H), 7.45–7.59
MS: m/z (%) = 346 (12) [M]+, 318 (100), 294 (19), 245 (26).
(m, 5 H, Ar–H) ppm. 13C NMR (CDCl3, 100 MHz): δ = 13.6, 19.9, C16H18N4O3S (346.4): calcd. C 55.48, H 5.24, N 16.17; found C
24.6 (2 C), 31.1, 42.5, 75.2, 125.9 (2 C), 129.4, 130.7 (3 C), 155.1, 55.64, H 5.36, N 16.01.
155.4, 174.5 (C=O) ppm. MS: m/z (%) = 299 (99) [M]+, 271 (100),
2-Arylamino-3-amino-4H-imidazol-4-ones 20: To a solution of vi-
256 (45), 214 (87), 159 (41). C16H21N5O (299.4): calcd. C 64.19, H
nyliminophosphorane 17[21] (2.25 g, 5 mmol) in dry dichlorometh-
7.07, N 23.39; found C 64.13, H 7.17, N 23.21.
ane (15 mL) was added aromatic isocyanate (5 mmol) under nitro-
2-Thioxo-6H-imidazo[1,2-b]-1,2,4-triazol-6-one (15): To a solution
of iminophosphorane 11 (4.78 g, 10 mmol) in dry dichloromethane
(15 mL) was added excess CS2 (10 mL) under nitrogen at room
temperature. After the reaction mixture was heated at reflux for
3 h, the precipitated solid was collected by filtration to give 15.
gen at room temperature. After the reaction mixture was stirred for
4–6 h, the solvent was removed under reduced pressure, and ether/
petroleum ether (1:2, 20 mL) was added to precipitate tri-
phenylphosphane oxide. The precipitate was filtered, and the sol-
vent was removed to give carbodiimides 18, which were used di-
White solid (yield 2.47 g, 95 %). M.p.: 240–241 °C. 1H NMR rectly without further purification. To the solution of 18 prepared
(CDCl3/TFA, 400 MHz): δ = 1.72 (s, 6 H, 2 CH3), 7.44–7.74 (m, 5
H, Ar–H) ppm. MS: m/z (%) = 260 (4) [M]+, 230 (100), 189 (21),
140 (28), 77 (22). C12H12N4OS (260.3): calcd. C 55.37, H 4.65, N
21.52; found C 55.18, H 4.69, N 21.65.
above in EtOH (15 mL) was added hydrazine hydrate (0.35 g,
6 mmol, 85%) in EtOH (5 mL). The mixture was stirred for 10 min
at room temperature and filtered to give 2-arylamino-3-amino-4H-
imidazol-4-ones 20. Isocyanate used for: 20a: phenyl isocyanate;
20b: 4-chlorophenyl isocyanate.
2-Alkylthio-6H-imidazo[1,2-b]-1,2,4-triazol-6-one (16): A mixture of
15 (0.26 g, 1 mmol), alkyl halide (1.2 mmol) and solid potassium
carbonate (0.28 g, 2 mmol) in CH3CN (10 mL) was stirred for 1–
4 h at room temperature or 50–60 °C and filtered; the filtrate was
condensed, and the residue was recrystallized from dichlorometh-
ane/petroleum ether to give 16. Alkyl halide and reaction condi-
tions used for: 16a: ethyl iodide, room temp.; 16b: n-propyl bro-
mide, 50 °C; 16c: n-butyl bromide, 60 °C; 16d: ethyl bromoacetate,
room temp.
3-Amino-3,5-dihydro-2-phenylamino-5-phenylmethylene-4H-
imidazol-4-one (20a): Yellow solid (yield 1.06 g, 76%). M.p.: 191–
1
193 °C. H NMR (CDCl3, 400 MHz): δ = 4.23 (s, 2 H, NH2), 6.88
(s, 1 H, =CH), 7.14–8.14 (m, 11 H, Ar–H and N–H) ppm. IR
(KBr): ν = 3340, 3322 (N–H), 1702 (C=O), 1660 (C=C), 1599,
˜
1156 cm–1. MS: m/z (%) = 278 (98) [M]+, 263 (19), 249 (22), 219
(37), 116 (100). C16H14N4O (278.3): calcd. C 69.05, H 5.07, N
20.13; found C 69.30, H 5.01, N 20.26.
3,5-Dihydro-5,5-dimethyl-2-ethylthio-3-phenyl-6H-imidazo[1,2-b]-
3-Amino-2-(4-chlorophenylamino)-3,5-dihydro-5-phenylmethylene-
1,2,4-triazol-6-one (16a): White solid (yield 0.24 g, 83 %). M.p.:
4H-imidazol-4-one (20b): Yellow solid (yield 1.16 g, 74 %). M.p.:
114–115 °C. H NMR (CDCl3, 400 MHz): δ = 1.45 (t, J = 7.2 Hz, 245–246 °C. 1H NMR ([D6]DMSO, 400 MHz): δ = 5.34 (s, 2 H,
1
3 H, CH3), 1.50 (s, 6 H, 2 CH3), 3.24 (q, J = 7.2 Hz, 2 H, SCH2),
NH2), 6.66 (s, 1 H, =CH), 7.30–8.14 (m, 9 H, Ar–H), 9.63 (s, 1 H,
7.44–7.55 (m, 5 H, Ar–H) ppm. 13C NMR (CDCl3, 100 MHz): δ = N–H) ppm. IR (KBr): ν = 3330, 3302 (N–H), 1728 (C=O), 1660
˜
14.1, 24.6 (2 C), 26.1, 76.3, 125.7 (2 C), 129.4, 130.1 (2 C), 130.3, (C=C), 1596, 1154 cm–1. MS: m/z (%) = 314 (30), 312 (88) [M]+,
155.9, 159.2, 174.3 (C=O) ppm. MS: m/z (%) = 288 (14) [M]+, 260
297 (21), 253 (18), 218 (13), 168 (68), 116 (100). C16H13ClN4O
4174
www.eurjoc.org
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2006, 4170–4176